| Market Cap | ₹2,412Cr |
| ROE | 6.31% |
| P/E Ratio(TTM) | 24.31 |
| EPS(TTM) | 1.81 |
| P/B Ratio | 2.02 |
| Dividend Yield | 0.45% |
| Industry P/E | 33.19 |
| Book Value | 21.83 |
| Debt to Equity | 0.13 |
| Face Value | 2 |
| Parent Organisation | Morepen Laboratories Limited |
| Managing Director | Mr. Sushil Suri |
| NSE Symbol | MOREPENLAB |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 37.64 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 31.38 | ||
| Cohance Lifesciences | NA (0.00%) | 71.87 | ||
| Wockhardt | NA (0.00%) | -417.83 |